ES522456A0 - Un metodo de preparacion de un derivado de monofosfato de guaminas antiviricas.(como divisional de la patente numero 515.193) - Google Patents

Un metodo de preparacion de un derivado de monofosfato de guaminas antiviricas.(como divisional de la patente numero 515.193)

Info

Publication number
ES522456A0
ES522456A0 ES522456A ES522456A ES522456A0 ES 522456 A0 ES522456 A0 ES 522456A0 ES 522456 A ES522456 A ES 522456A ES 522456 A ES522456 A ES 522456A ES 522456 A0 ES522456 A0 ES 522456A0
Authority
ES
Spain
Prior art keywords
compounds
preparation
guaminas
antiviric
divisional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES522456A
Other languages
English (en)
Other versions
ES8406547A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES522456A0 publication Critical patent/ES522456A0/es
Publication of ES8406547A1 publication Critical patent/ES8406547A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ES522456A 1981-08-26 1983-05-16 Un metodo de preparacion de un derivado de monofosfato de guaminas antiviricas.(como divisional de la patente numero 515.193) Expired ES8406547A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29660481A 1981-08-26 1981-08-26

Publications (2)

Publication Number Publication Date
ES522456A0 true ES522456A0 (es) 1984-08-01
ES8406547A1 ES8406547A1 (es) 1984-08-01

Family

ID=23142740

Family Applications (2)

Application Number Title Priority Date Filing Date
ES515193A Expired ES8402837A1 (es) 1981-08-26 1982-08-23 Un metodo de preparacion de quaninas antiviricas.
ES522456A Expired ES8406547A1 (es) 1981-08-26 1983-05-16 Un metodo de preparacion de un derivado de monofosfato de guaminas antiviricas.(como divisional de la patente numero 515.193)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES515193A Expired ES8402837A1 (es) 1981-08-26 1982-08-23 Un metodo de preparacion de quaninas antiviricas.

Country Status (14)

Country Link
EP (1) EP0074306B1 (es)
JP (3) JPS5877881A (es)
KR (1) KR840001168A (es)
AT (1) ATE34750T1 (es)
AU (1) AU8755282A (es)
CA (1) CA1300622C (es)
DE (1) DE3278561D1 (es)
DK (1) DK379782A (es)
ES (2) ES8402837A1 (es)
GR (1) GR76861B (es)
IL (1) IL66640A0 (es)
NZ (1) NZ201662A (es)
PT (1) PT75463B (es)
ZA (1) ZA826196B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
ES8403128A1 (es) * 1981-08-11 1983-10-01 Wellcome Found "un procedimiento para preparar derivados de purina".
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
JPS58135885A (ja) * 1982-02-01 1983-08-12 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド 置換されたプリン、その製造方法およびそれからなる抗ウイルス剤
US4556659A (en) * 1982-08-09 1985-12-03 Syntex (U.S.A.) Inc. Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents
EP0105486A3 (en) * 1982-09-30 1984-05-16 Syntex (U.S.A.) Inc. 1-monophosphate esters, 1,3-bisphosphate esters and cyclic phosphate esters of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine as antiviral agents
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4544634A (en) * 1982-10-14 1985-10-01 Burroughs Wellcome Co. Method of producing acyclovir
US4462986A (en) * 1982-11-04 1984-07-31 Ens Bio Logicals, Inc. Synergistic anti-herpes compositions
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
GB2150570B (en) * 1983-05-24 1987-04-08 Stanford Res Inst Int Novel antiviral agents
IL72173A0 (en) * 1983-06-24 1984-10-31 Merck & Co Inc Guanine derivatives,their preparation and pharmaceutical compositions containing them
JPS6023380A (ja) * 1983-06-24 1985-02-05 メルク・エンド・カムパニー・インコーポレーテッド 抗ウイルス剤
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US4670424A (en) * 1983-09-19 1987-06-02 Merck & Co., Inc. Cyclic pyrophosphates of purine and pyrimidine acyclonucleosides
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
EP0138683A3 (en) * 1983-09-30 1988-01-20 Merck & Co. Inc. Purine derivatives, their application in anti-viral compositions
IL73682A (en) * 1983-12-20 1991-08-16 Medivir Ab Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation
DE3571810D1 (en) * 1984-01-26 1989-08-31 Merck & Co Inc Substituted butyl guanines and their utilization in antiviral compositions
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
EP0184473A1 (en) * 1984-10-26 1986-06-11 Merck & Co. Inc. Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives
HUT39145A (en) * 1984-12-12 1986-08-28 Syntex Inc Process for preparing alkoxy-methyl-ether and alkoxy-methyl ester derivatives
SE8406538D0 (sv) 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
CA1330794C (en) * 1987-03-27 1994-07-19 Phillip Frost Anti-viral compounds, dosage forms and methods
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
US5068119A (en) * 1990-09-28 1991-11-26 Nabisco Brands, Inc. Acid-hydrolyzable ester derivatives as low calorie fat mimetics
GB2260319B (en) 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
US5532225A (en) * 1992-07-31 1996-07-02 Sri International Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods
US5565565A (en) * 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
CN1091445C (zh) * 1999-12-29 2002-09-25 湖北省医药工业研究院 抗病毒药物中间体、它们的制备及应用
EP1565470A2 (en) * 2002-10-31 2005-08-24 Ranbaxy Laboratories Limited Process for the preparation of ganciclovir
CN113024559B (zh) * 2019-12-25 2022-03-29 上药康丽（常州）药业有限公司 一种异更昔洛韦的制备方法
KR20240077879A (ko) * 2022-11-25 2024-06-03 롯데케미칼 주식회사 올레핀 올리고머화의 부산물 저감 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
ES8403128A1 (es) * 1981-08-11 1983-10-01 Wellcome Found "un procedimiento para preparar derivados de purina".
JPS58135885A (ja) * 1982-02-01 1983-08-12 シンテツクス（ユ−・エス・エイ）インコ−ポレイテツド 置換されたプリン、その製造方法およびそれからなる抗ウイルス剤

Also Published As

Publication number Publication date
EP0074306A2 (en) 1983-03-16
JPH04217940A (ja) 1992-08-07
JPS5877881A (ja) 1983-05-11
ES515193A0 (es) 1984-03-01
ES8402837A1 (es) 1984-03-01
GR76861B (es) 1984-09-04
ES8406547A1 (es) 1984-08-01
DK379782A (da) 1983-02-27
DE3278561D1 (en) 1988-07-07
NZ201662A (en) 1986-07-11
EP0074306B1 (en) 1988-06-01
PT75463B (en) 1986-08-28
CA1300622C (en) 1992-05-12
IL66640A0 (en) 1982-12-31
ZA826196B (en) 1984-04-25
JPH05286974A (ja) 1993-11-02
JPH0729979B2 (ja) 1995-04-05
PT75463A (en) 1982-09-01
JPH0480914B2 (es) 1992-12-21
ATE34750T1 (de) 1988-06-15
AU8755282A (en) 1983-03-03
KR840001168A (ko) 1984-03-28
JPH0714938B2 (ja) 1995-02-22
EP0074306A3 (en) 1983-05-25

Similar Documents

Publication Publication Date Title
ES522456A0 (es) Un metodo de preparacion de un derivado de monofosfato de guaminas antiviricas.(como divisional de la patente numero 515.193)
MC1475A1 (fr) Procede de preparation de derives de la purine a action anti-virale
JPS61280500A (ja) ヌクレオシド化合物
SE7509675L (sv) Forfarande for framstellning av purinforeningar och salter derav
ATE45580T1 (de) 9-(2-hydroxyethoxymethyl)guanin-derivate.
BE901545A (fr) Nouveaux derives de la furo-(3,4-c)-pyridine substitues en position 6, un procede pour leur preparation et compositions therapeutiques a base de ces derives.
KR850700136A (ko) 신규 구아닌 유도체
ES499870A0 (es) Un procedimiento para la preparacion de derivados de indano
IT8620846A0 (it) Derivati di acido valproico e di acido (e)-2-valproenoico, procedimento per la loro preparazione e relative composizioni farmaceutiche.
FI861655A0 (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi
ES2037095T3 (es) Un procedimiento para preparar una composicion farmaceutica.
BE844157A (fr) Procede de preparation d'ethers perfluores par irradiation lumineuse de perfluoro-cetones
OA06310A (fr) Nouveaux dérivés N-substitués de l'acide aziridinyl-2-carboxylique et leur procédé de préparation.
ES456407A1 (es) Un metodo de preparacion de una purina sustituida.
EP0383361A2 (en) 1-Beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide for use in medical treatment of humans
FR2416214A1 (fr) Derives d'acide naphtyl-1 acetique, leur procede de preparation et leur application therapeutique
US5250688A (en) Purine derivatives
FR2375184A1 (fr) Nouveaux derives de l'acide benzoyl phenoxy acetique, leur procede de preparation et leur application en therapeutique
FR2302727A1 (fr) Nouveaux derives d'acide prostanique, leur procede de preparation et leur application en tant que medicaments
ATE23856T1 (de) Derivate der d-2-(6-methoxy-2-naphthyl)propions|ure mit therapeutischer wirkung, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
BE863842A (fr) Procede de preparation de nouveaux derives d'acide indolyglyoxylique utiles comme medicaments
FR2335209A1 (fr) Nouveaux derives de l'acide prostanoique, leur procede de preparation et leur application comme medicaments
FR2312239A1 (fr) Nouveaux derives de l'acide prostanoique, procede de preparation et application comme medicaments
GEP19970666B (en) Process for the preparation of purine derivatives